Proposed Collection; 60-day Comment Request; Outcome Evaluation of the Broadening Experiences in Scientific Training (BEST) Program, 50921-50922 [2014-20268]
Download as PDF
<![CDATA[
tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 165 / Tuesday, August 26, 2014 / Notices
41. Darrell Maukonen, The Villages,
Florida, Court of Federal Claims No:
14–0648V
42. John Poh, Bainbridge Island,
Washington, Court of Federal
Claims No: 14–0649V
43. Ashley M. Pietro, Linwood, New
Jersey, Court of Federal Claims No:
14–0652V
44. June Reed on behalf of M. C.,
Shreveport, Louisiana, Court of
Federal Claims No: 14–0653V
45. Karen Woolley, Buena Vista,
California, Court of Federal Claims
No: 14–0654V
46. George Seaberg and Darla Seaberg on
behalf of Calan Seaberg, Dallas,
Texas, Court of Federal Claims No:
14–0655V
47. Stephanie Kuhn on behalf of L. K.,
Augusta, Georgia, Court of Federal
Claims No: 14–0656V
48. Carrie Hodkinson and Chad
Hodkinson on behalf of E. H., New
York, New York, Court of Federal
Claims No: 14–0660V
49. Patricia Elliott, Groveland,
California, Court of Federal Claims
No: 14–0661V
50. Gretchen Brady Ebright,
Hummelstown, Pennsylvania, Court
of Federal Claims No: 14–0662V
51. Carl Silvestri and Susan Silvestri on
behalf of S. S., Boston,
Massachusetts, Court of Federal
Claims No: 14–0666V
52. Jane Goering, Boston, Massachusetts,
Court of Federal Claims No: 14–
0667V
53. Aimee Deak, Boston, Massachusetts,
Court of Federal Claims No: 14–
0668V
54. Gaines Hearns, Birmingham,
Alabama, Court of Federal Claims
No: 14–0669V
55. Larry Scott Pearce, Boston,
Massachusetts, Court of Federal
Claims No: 14–0670V
56. Lindsey Pelton on behalf of Nickson
Law Pelton, Southeast Conyers,
Georgia, Court of Federal Claims
No: 14–0674V
57. Holly Brannigan on behalf of K. B.,
Piermont, New York, Court of
Federal Claims No: 14–0675V
58. Charles Storey, Eugene, Oregon,
Court of Federal Claims No: 14–
0676V
59. Eddie David Dukes, Summerville,
South Carolina, Court of Federal
Claims No: 14–0677V
60. Shirley Darlene Pardue,
Chattanooga, Tennessee, Court of
Federal Claims No: 14–0678V
VerDate Mar<15>2010
21:48 Aug 25, 2014
Jkt 232001
61. Cynthia Rae Torres, Dodge City,
Kansas, Court of Federal Claims No:
14–0679V
62. Edward Anthony, Dickinson, Texas,
Court of Federal Claims No: 14–
0680V
63. Thomas M. Tafoya on behalf of R.
T., Deceased, Rio Rancho, New
Mexico, Court of Federal Claims
No: 14–0683V
64. Darren Rose and Heejin Jinny Rose
on behalf of K. R., Tenafly, New
Jersey, Court of Federal Claims No:
14–0684V
65. Shirley F. Crookshanks, Richmond,
Virginia, Court of Federal Claims
No: 14–0685V
66. Marta Garcia, New York, New York,
Court of Federal Claims No: 14–
0688V
[FR Doc. 2014–20310 Filed 8–25–14; 8:45 am]
BILLING CODE 4165–15–P
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
To Submit Comments and For Further
Information: To obtain a copy of the
data collection plans and instruments,
submit comments in writing, or request
more information on the proposed
project, contact: Dr. Patricia Labosky,
Office of Strategic Coordination,
Division of Program Coordination,
Planning, and Strategic Initiatives,
Office of the Director, NIH, 1 Center
Drive, MSC 0189, Building 1, Room
214A, Bethesda, MD 20892–0189; or call
301–594–4863; or email your request,
including your address to:
Workforce_Award@mail.nih.gov. Formal
requests for additional plans and
instruments must be requested in
writing.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Proposed Collection: Outcome
Evaluation of the Broadening
Experiences in Scientific Training
(BEST) Program, 0925-New, Office of
Strategic Coordination, Division of
Program Coordination, Planning, and
Strategic Initiatives, Office of the
Director, National Institutes of Health
(NIH).
Need and Use of Information
Collection: The goal of the BEST
program is to complement and broaden
both doctoral and postdoctoral
traditional training experiences. The
evaluation study will assess three
desired outcomes of the BEST Program:
(1) Changes in understanding of career
opportunities, confidence to make
career decisions, and attitudes towards
career opportunities; (2) reduction in
time desired, not training, nonterminal
career opportunities, and reduction in
time in postdoctoral positions; (3)
creation/further development of
institutional infrastructure to continue
BEST-like activities. The findings will
be used to (1) inform the NIH Director,
the BEST program staff, and the
biomedical training community on the
outcomes of the program; and (2)
disseminate best practices across
biomedical training programs and the
research community.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The estimated
annualized burden hours are 16,502.
DATES:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-day Comment
Request; Outcome Evaluation of the
Broadening Experiences in Scientific
Training (BEST) Program
In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
Office of Strategic Coordination (OSC),
Division of Program Coordination,
Planning, and Strategic Initiatives
(DPCPSI), Office of the Director (OD),
the National Institutes of Health (NIH),
will publish periodic summaries of
proposed projects to be submitted to the
Office of Management and Budget
(OMB) for review and approval.
Written comments and/or suggestions
from the public and affected agencies
are invited on one or more of the
following points: (1) Whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
SUMMARY:
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
50921
E:\FR\FM\26AUN1.SGM
26AUN1
50922
Federal Register / Vol. 79, No. 165 / Tuesday, August 26, 2014 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Graduate Student—Entrance Survey (online survey) .....................................
Graduate Student—Interim Survey (online survey) .........................................
Graduate Student—Graduation Survey (online survey) ..................................
Graduate Student—Post-graduation 2-year Follow-up Survey (online survey) ...............................................................................................................
Postdoctoral Scientist—Entrance Survey (online survey) ...............................
Postdoctoral Scientist—Exit Survey (online survey) .......................................
Postdoctoral Scientist—Post-exit 2-year Follow-up Survey (online survey) ...
Principal Investigators—Annual Interview (phone—end of each year of
award ) .........................................................................................................
Dated: August 20, 2014.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2014–20268 Filed 8–25–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S. in accordance with
35 U.S.C. 209 and 37 CFR part 404 to
achieve expeditious commercialization
of results of federally-funded research
and development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
FOR FURTHER INFORMATION CONTACT:
Licensing information and copies of the
U.S. patent applications listed below
may be obtained by writing to the
indicated licensing contact at the Office
of Technology Transfer, National
Institutes of Health, 6011 Executive
Boulevard, Suite 325, Rockville,
Maryland 20852–3804; telephone: 301–
496–7057; fax: 301–402–0220. A signed
Confidential Disclosure Agreement will
be required to receive copies of the
patent applications.
SUPPLEMENTARY INFORMATION:
Technology descriptions follow.
tkelley on DSK3SPTVN1PROD with NOTICES
SUMMARY:
A Rabbit Anti-pT1989 ATR Monoclonal
Antibody for Use in Immunoassays
Description of Technology: This
technology concerns a novel
VerDate Mar<15>2010
21:48 Aug 25, 2014
Jkt 232001
Frm 00039
Fmt 4703
Sfmt 4703
Average
burden per
response
(in hours)
Annual hour
burden
5,901
14,753
3,934
1
1
1
45/60
20/60
20/60
4,426
4,918
1,311
3,934
3,777
2,518
2,518
1
1
1
1
20/60
45/60
20/60
20/60
1,311
2,833
839
839
25
1
1
25
monoclonal antibody for selecting new
anti-cancer compounds.
The active form of ATR (ataxia
telangiectasia-mutated and Rad3related) kinase is phosphorylated at
Threonine 1989 site (T1989). The
monoclonal antibody binds the
phosphorylated Threonine 1989
(T1989). The phosphorylated ATR
senses DNA damage response and leads
to cell cycle arrest. Targeting at ATR,
anti-cancer drugs may induce cancer
cell death.
This technology can be applied into
stable and immunoassays on multiple
platforms for measuring ATR activation
and inhibition and may inform
therapeutic decisions for cancer
treatment.
Potential Commercial Applications:
• Antibody specifically against
phosphorylated ATR (at T1989 site).
• Application in assays to develop
personalized medicine for pT1989 ATRrelated disease.
• Application in assays for selecting
measuring ATR modulation.
• Application in assays for selecting
ATR inhibitors.
Competitive Advantages:
• Novel antibody against ATR
phosphorylated at T1989.
• Possibility to establish stable and
effective immunoassays to select drugs
specifically targeting ATR.
• Works in western blot and IFA
applications on crude (unenriched) cell
lysates.
• Works in standard processed
clinical and preclinical samples.
• Can be used to report drug activity.
Development Stage:
• In vitro data available.
• In vivo data available (animal).
• Prototype.
Inventors: Thomas D. Pfister (SAICFrederick), Allison M. Marrero (SAICFrederick), Ralph E. Parchment (SAICFrederick), James H. Doroshow (NCI).
Intellectual Property: HHS Reference
No. E–001–2014/0—US Provisional
PO 00000
Frequency of
response
Application No. 61/893,070 filed 18 Oct
2013.
Licensing Contact: Surekha Vathyam,
Ph.D.; 301–435–4076;
vathyams@mail.nih.gov.
Monitoring the Effects of Sleep
Deprivation Using Neuronal
Avalanches
Description of Technology:
Investigators at the National Institute of
Mental Health have discovered a novel
method for monitoring the effects of
sleep deprivation on brain activity.
Sleep deprivation has been known to
adversely affect basic cognitive abilities,
such as object recognition and decision
making, even leading to hallucinations
and epileptic seizures. This invention
measures the degree of sleep
deprivation and decrease in behavioral
performance directly from resting brain
activity. A deviation from optimal
avalanche parameters correlates with
duration of wakefulness and decrease in
performance.
Potential Commercial Applications:
• Monitor wakefulness, reaction time.
• Potential application for monitoring
sleep-deprived first-responders (e.g.,
military, EMT, etc.)
Competitive Advantages:
• Continuously monitors brain
activity.
• Non-invasive.
Development Stage:
• In vivo data available (human).
• Prototype.
Inventors: Dietmar Plenz (NIMH),
Oren Shriki (NIMH), Christian Meisel
(NIMH), Giulio Tononi (Univ.
Wisconsin).
Publication: Meisel C, et al. Fading
signatures of critical brain dynamics
during sustained wakefulness in
humans. J Neurosci. 2013 Oct
30;33(44):17363–72. [PMID 24174669].
Intellectual Property: HHS Reference
No. E–345–2013/0—US Application No.
61/866,962 filed 16 Aug 2013.
Related Technologies: HHS Reference
No. E–294–2005/1–
E:\FR\FM\26AUN1.SGM
26AUN1
]]>Agencies
[Federal Register Volume 79, Number 165 (Tuesday, August 26, 2014)]
[Notices]
[Pages 50921-50922]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-20268]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-day Comment Request; Outcome Evaluation
of the Broadening Experiences in Scientific Training (BEST) Program
SUMMARY: In compliance with the requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995, for opportunity for public comment
on proposed data collection projects, the Office of Strategic
Coordination (OSC), Division of Program Coordination, Planning, and
Strategic Initiatives (DPCPSI), Office of the Director (OD), the
National Institutes of Health (NIH), will publish periodic summaries of
proposed projects to be submitted to the Office of Management and
Budget (OMB) for review and approval.
Written comments and/or suggestions from the public and affected
agencies are invited on one or more of the following points: (1)
Whether the proposed collection of information is necessary for the
proper performance of the function of the agency, including whether the
information will have practical utility; (2) The accuracy of the
agency's estimate of the burden of the proposed collection of
information, including the validity of the methodology and assumptions
used; (3) Ways to enhance the quality, utility, and clarity of the
information to be collected; and (4) Ways to minimize the burden of the
collection of information on those who are to respond, including the
use of appropriate automated, electronic, mechanical, or other
technological collection techniques or other forms of information
technology.
To Submit Comments and For Further Information: To obtain a copy of
the data collection plans and instruments, submit comments in writing,
or request more information on the proposed project, contact: Dr.
Patricia Labosky, Office of Strategic Coordination, Division of Program
Coordination, Planning, and Strategic Initiatives, Office of the
Director, NIH, 1 Center Drive, MSC 0189, Building 1, Room 214A,
Bethesda, MD 20892-0189; or call 301-594-4863; or email your request,
including your address to: Workforce_Award@mail.nih.gov. Formal
requests for additional plans and instruments must be requested in
writing.
DATES: Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 60 days
of the date of this publication.
Proposed Collection: Outcome Evaluation of the Broadening
Experiences in Scientific Training (BEST) Program, 0925-New, Office of
Strategic Coordination, Division of Program Coordination, Planning, and
Strategic Initiatives, Office of the Director, National Institutes of
Health (NIH).
Need and Use of Information Collection: The goal of the BEST
program is to complement and broaden both doctoral and postdoctoral
traditional training experiences. The evaluation study will assess
three desired outcomes of the BEST Program: (1) Changes in
understanding of career opportunities, confidence to make career
decisions, and attitudes towards career opportunities; (2) reduction in
time desired, not training, nonterminal career opportunities, and
reduction in time in postdoctoral positions; (3) creation/further
development of institutional infrastructure to continue BEST-like
activities. The findings will be used to (1) inform the NIH Director,
the BEST program staff, and the biomedical training community on the
outcomes of the program; and (2) disseminate best practices across
biomedical training programs and the research community.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The estimated annualized burden
hours are 16,502.
[[Page 50922]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average burden
Type of respondents Number of Frequency of per response Annual hour
respondents response (in hours) burden
----------------------------------------------------------------------------------------------------------------
Graduate Student--Entrance Survey (online 5,901 1 45/60 4,426
survey)........................................
Graduate Student--Interim Survey (online survey) 14,753 1 20/60 4,918
Graduate Student--Graduation Survey (online 3,934 1 20/60 1,311
survey)........................................
Graduate Student--Post-graduation 2-year Follow- 3,934 1 20/60 1,311
up Survey (online survey)......................
Postdoctoral Scientist--Entrance Survey (online 3,777 1 45/60 2,833
survey)........................................
Postdoctoral Scientist--Exit Survey (online 2,518 1 20/60 839
survey)........................................
Postdoctoral Scientist--Post-exit 2-year Follow- 2,518 1 20/60 839
up Survey (online survey)......................
Principal Investigators--Annual Interview 25 1 1 25
(phone--end of each year of award )............
----------------------------------------------------------------------------------------------------------------
Dated: August 20, 2014.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2014-20268 Filed 8-25-14; 8:45 am]
BILLING CODE 4140-01-P
